IRMA-International.org: Creator of Knowledge
Information Resources Management Association
Advancing the Concepts & Practices of Information Resources Management in Modern Organizations

Chemosensitivity Prediction of Tumours based on Expression, miRNA, and Proteomics Data

Chemosensitivity Prediction of Tumours based on Expression, miRNA, and Proteomics Data
View Sample PDF
Author(s): I. Tsamardinos (ICS-FORTH, Greece & University of Crete, Greece), G. Borboudakis (ICS-FORTH, Greece & University of Crete, Greece), E. G. Christodoulou (BIOTEC Technische Universität Dresden, Germany)and O. D. Røe (Levanger Hospital—Nord-Trøndelag Health Trust, Norway, & Norwegian University of Science and Technology, Norway)
Copyright: 2013
Pages: 19
Source title: Bioinformatics: Concepts, Methodologies, Tools, and Applications
Source Author(s)/Editor(s): Information Resources Management Association (USA)
DOI: 10.4018/978-1-4666-3604-0.ch032

Purchase

View Chemosensitivity Prediction of Tumours based on Expression, miRNA, and Proteomics Data on the publisher's website for pricing and purchasing information.

Abstract

The chemosensitivity of tumours to specific drugs can be predicted based on molecular quantities, such as gene expressions, miRNA expressions, and protein concentrations. This finding is important for improving drug efficacy and personalizing drug use. In this paper, the authors present an analysis strategy that, compared to prior work, retains more information in the data for analysis and may lead to improved chemosensitivity prediction. The authors apply improved methods for estimating the GI50 value of a drug (an indicator of the response to the drug), regression methods for constructing predictive models of the GI50 value, advanced variable selection techniques, such as MMPC, and a multi-task variable selection technique for identifying a small-size signature that is simultaneously predictive for several drugs and cell lines. The methods are applied on gene expression, miRNA expression, and proteomics data from 53 tumour cell lines after treatment with 120 drugs, obtained from the National Cancer Institute databases. A biological interpretation and discussion of the results is presented for the most clinically important subset of 14 drugs.

Related Content

Linkon Chowdhury, Md Sarwar Kamal, Shamim H. Ripon, Sazia Parvin, Omar Khadeer Hussain, Amira Ashour, Bristy Roy Chowdhury. © 2024. 20 pages.
Mousomi Roy. © 2024. 21 pages.
Nassima Dif, Zakaria Elberrichi. © 2024. 20 pages.
Pyingkodi Maran, Shanthi S., Thenmozhi K., Hemalatha D., Nanthini K.. © 2024. 16 pages.
Mohamed Nadjib Boufenara, Mahmoud Boufaida, Mohamed Lamine Berkane. © 2024. 16 pages.
Meroua Daoudi, Souham Meshoul, Samia Boucherkha. © 2024. 25 pages.
Zhongyu Lu, Qiang Xu, Murad Al-Rajab, Lamogha Chiazor. © 2024. 56 pages.
Body Bottom